Michele Solis

Journalist

Michele Solis is a freelance science writer based in Seattle, Washington

Beyond valproate: treatment dilemmas for women with epilepsy continue

For women with epilepsy, seizure control during pregnancy is a moving target, and with increasing knowledge about the risks of antiepileptics on foetal development, prescribers are having to balance the risks and benefits for both mother and baby.…

‘Beyond our wildest dreams’ – CAR-T therapies in multiple myeloma

CAR-T therapies have been licensed in the UK since 2018 for the treatment of B cell lymphoma. But with positive results emerging for their use in multiple myeloma, and the promise of potential in solid tumours, excitement around CAR-T continues to grow.…

Personalised treatment for depression on the horizon: predicting response to antidepressants

Only one-third of patients with depression benefit from the first antidepressant they try, but researchers are striving to find biological features that predict how a person will respond to particular drugs so they can tailor treatment from the beginning.…